Alert: Rating Downgrade (4/8/24)-OncoGenex Pharmaceuticals Inc (NASDAQ: VRSK).
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for OncoGenex Pharmaceuticals Inc (NASDAQ: VRSK) weakened in the last week. VRSK’s current Value Trend Rating is D and the prior […]